Unknown

Dataset Information

0

Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified β-Ga2O3:Cr3+ nanoparticles.


ABSTRACT: The prevalence of antibiotic resistance and lack of alternative drugs have posed an increasing threat to public health. Here, we prepared β-Ga2O3:Cr3+ nanoparticles modified with ICAM1-antibody-conjugated TPGS (I-TPGS/Ga2O3) as a novel antibiotic carrier for the treatment of drug-resistant infections. Methods: I-TPGS/Ga2O3 were firstly characterized by measuring particle size, morphology, crystal structure, drug loading capacity, and in vitro drug release behaviors. The in vitro antibacterial activities of I-TPGS/Ga2O3/TIG were evaluated using standard and drug-resistant bacteria. The internalization of I-TPGS/Ga2O3 was observed by fluorescence confocal imaging, and the expression levels of the efflux pump genes of TRKP were analyzed by real-time RT-PCR. In vitro cellular uptake and in vivo biodistribution study were performed to investigate the targeting specificity of I-TPGS/Ga2O3 using HUEVC and acute pneumonia mice, respectively. The in vivo anti-infective efficacy and biosafety of I-TPGS/Ga2O3/TIG were finally evaluated using acute pneumonia mice. Results: It was found that TPGS could down-regulate the over-expression of the efflux pump genes, thus decreasing the efflux pump activity of bacteria. I-TPGS/Ga2O3 with small particle size and uniform distribution facilitated their internalization in bacteria, and the TPGS modification resulted in a significant reduction in the efflux of loaded antibiotics. These properties rendered the encapsulated tigecycline to exert a stronger antibacterial activity both in vitro and in vivo. Additionally, targeted delivery of I-TPGS/Ga2O3 mediated by ICAM1 antibodies contributed to a safe and effective therapy. Conclusion: It is of great value to apply I-TPGS/Ga2O3 as a novel and effective antibiotic delivery system for the treatment of drug-resistant infections.

SUBMITTER: Kang XQ 

PROVIDER: S-EPMC6568169 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified β-Ga<sub>2</sub>O<sub>3</sub>:Cr<sup>3+</sup> nanoparticles.

Kang Xu-Qi XQ   Shu Gao-Feng GF   Jiang Sai-Ping SP   Xu Xiao-Lin XL   Qi Jing J   Jin Fei-Yang FY   Liu Di D   Xiao Yong-Hong YH   Lu Xiao-Yang XY   Du Yong-Zhong YZ  

Theranostics 20190413 10


The prevalence of antibiotic resistance and lack of alternative drugs have posed an increasing threat to public health. Here, we prepared β-Ga<sub>2</sub>O<sub>3</sub>:Cr<sup>3+</sup> nanoparticles modified with ICAM1-antibody-conjugated TPGS (I-TPGS/Ga<sub>2</sub>O<sub>3</sub>) as a novel antibiotic carrier for the treatment of drug-resistant infections. <b>Methods</b>: I-TPGS/Ga<sub>2</sub>O<sub>3</sub> were firstly characterized by measuring particle size, morphology, crystal structure, drug  ...[more]

Similar Datasets

| S-EPMC5807884 | biostudies-literature
| S-EPMC8991142 | biostudies-literature
| S-EPMC7234819 | biostudies-literature
2014-07-11 | GSE59284 | GEO
| S-EPMC6311082 | biostudies-literature
| S-EPMC11377996 | biostudies-literature
| S-EPMC10099448 | biostudies-literature
| S-EPMC11372556 | biostudies-literature
| S-EPMC9027598 | biostudies-literature
2014-07-11 | E-GEOD-59284 | biostudies-arrayexpress